Physician profile
Kristie Hack
NPI 1508115007
$3,223.38
in general payments reported to CMS, 2019-2025
33 companies · $420 in 2025
The $420 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,187 · 2022: $1,170 · 2023: $188 · 2024: $259 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $866.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $866.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $717.91 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $620.78 | 2021-2022 | |
| Janssen Biotech, INC. | $270.59 | 2021-2022 | |
| Gilead Sciences, INC. | $212.02 | 2021-2022 | |
| Novo Nordisk INC | $197.67 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $179.70 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Ironwood Pharmaceuticals, INC | $120.82 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $105.03 | 2024-2025 | Jardiance |
| Pfizer INC. | $86.09 | 2021-2025 | |
| Idorsia Pharmaceuticals US INC | $73.60 | 2023 | Quviviq |
| Daiichi Sankyo INC. | $55.90 | 2021-2022 | |
| Qol Medical, LLC | $48.20 | 2021 | |
| Inari Medical, INC. | $43.41 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astrazeneca Pharmaceuticals LP | $43.09 | 2025 | Airsupra |
| Organon LLC | $40.25 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $36.86 | 2021 | |
| Phathom Pharmaceuticals, INC. | $32.98 | 2025 | Voquezna |
| Celgene Corporation | $32.88 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.36 | 2021-2022 | |
| Braintree Laboratories, INC. | $30.08 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $27.27 | 2021-2022 | |
| Medtronic, INC. | $25.50 | 2025 | Inceptiv |
| Amgen INC. | $24.99 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.56 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $22.61 | 2021 | |
| Philips North America LLC | $19.80 | 2024 | (Ck4) Mcot |
| Insulet Corporation | $19.29 | 2023 | Omnipod |
| Ardelyx, INC. | $14.98 | 2022 | |
| Echosens North America, INC. | $14.65 | 2021 | |
| Exact Sciences Corporation | $13.74 | 2024 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $13.30 | 2024 | |
| Inspire Medical Systems, INC. | $12.91 | 2023 | Inspire |
| Cequr Corporation | $12.56 | 2024 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristie Hack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.